JP2000505422A - 婦人科における障害を治療するためのlhrh類似化合物および抗エストロゲンからなる製薬的組み合わせ製剤 - Google Patents
婦人科における障害を治療するためのlhrh類似化合物および抗エストロゲンからなる製薬的組み合わせ製剤Info
- Publication number
- JP2000505422A JP2000505422A JP9527295A JP52729597A JP2000505422A JP 2000505422 A JP2000505422 A JP 2000505422A JP 9527295 A JP9527295 A JP 9527295A JP 52729597 A JP52729597 A JP 52729597A JP 2000505422 A JP2000505422 A JP 2000505422A
- Authority
- JP
- Japan
- Prior art keywords
- lhrh
- analog
- use according
- antiestrogen
- lhrh analog
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.LHRH類似化合物もしくはLHRH類似化合物の組み合わせ物、およびラ ロキシフェン、ドロロキシフェン、セントクロマンの化合物またはこれらの誘導 体の群から選択される、組織選択的エストロゲン作用を有する抗エストロゲンの 、婦人科における障害、特に子宮内膜症および筋腫の治療のための使用。 2.LHRH類似化合物がLHRHアゴニストまたはLHRHアンタゴニストで ある請求の範囲1記載の使用。 3.LHRH類似化合物が、ロイプロレリン、セトロレリックス、ブセレリン、 アンチド、Ac−D−Nal−D−Cpa−D−Pal−Ser−Tyr−D− Cit−Leu−Lys(Mor)−Pro−D−Ala−NH2、ラモレリッ クス、ゾラデックスの化合物またはこれらの誘導体の群から選択される請求の範 囲1または2記載の使用。 4.LHRH類似化合物もしくはLHRH類似化合物の組み合わせ物が経口で生 体使用可能である請求の範囲1から3までのいずれか1項記載の使用。 5.LHRH類似化合物が非ペプチドのLHRHアゴニストまたはLHRHアン タゴニストである請求の範囲1から4までのいずれか1項記載の使用。 6.抗エストロゲンがラロキシフェンタイプである請求の範囲1から5までのい ずれか1項記載の使用。 7.2つの作用物質が別々の投与形で存在する請求の範囲1から6までのいずれ か1項記載の使用。 8.2つの作用物質が一緒の投与形で存在する請求の範囲1から6までのいずれ か1項記載の使用。 9.HRH類似化合物および抗エストロゲンを同時におよび/または時間的にず らせて使用する請求の範囲7または8記載の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19604231.3 | 1996-01-29 | ||
DE19604231A DE19604231A1 (de) | 1996-01-29 | 1996-01-29 | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
PCT/EP1997/000395 WO1997027863A1 (de) | 1996-01-29 | 1997-01-29 | Pharmazeutisches kombinationspräparat aus lhrh-analoga und antiöstrogenen zur behandlung von gynäcologischen störungen |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000505422A true JP2000505422A (ja) | 2000-05-09 |
Family
ID=7784640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9527295A Ceased JP2000505422A (ja) | 1996-01-29 | 1997-01-29 | 婦人科における障害を治療するためのlhrh類似化合物および抗エストロゲンからなる製薬的組み合わせ製剤 |
Country Status (20)
Country | Link |
---|---|
US (3) | US7309691B2 (ja) |
EP (1) | EP0877621A1 (ja) |
JP (1) | JP2000505422A (ja) |
KR (1) | KR19990082080A (ja) |
CN (1) | CN1209750A (ja) |
BG (1) | BG63248B1 (ja) |
BR (1) | BR9707210A (ja) |
CZ (1) | CZ239198A3 (ja) |
DE (1) | DE19604231A1 (ja) |
EA (1) | EA001178B1 (ja) |
HU (1) | HUP9901288A3 (ja) |
IL (1) | IL125557A0 (ja) |
MX (1) | MX9806082A (ja) |
NO (1) | NO983465L (ja) |
PL (1) | PL328066A1 (ja) |
SK (1) | SK98798A3 (ja) |
TR (1) | TR199801452T2 (ja) |
TW (1) | TW577735B (ja) |
WO (1) | WO1997027863A1 (ja) |
ZA (1) | ZA97741B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006098371A1 (ja) * | 2005-03-16 | 2006-09-21 | Masao Igarashi | 子宮内膜症および子宮腺筋症の治療剤および予防剤 |
JP2013528626A (ja) * | 2010-06-16 | 2013-07-11 | アンドルシェルシュ・インコーポレイテッド | エストロゲン関連疾患を治療するまたは予防するための方法 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6828415B2 (en) * | 1993-02-19 | 2004-12-07 | Zentaris Gmbh | Oligopeptide lyophilisate, their preparation and use |
US6096764A (en) * | 1997-08-21 | 2000-08-01 | Eli Lilly And Company | Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration |
DE69912422T2 (de) * | 1998-04-23 | 2004-08-19 | Zentaris Gmbh | Methode zur behandlung von fruchtbarkeitsstörungen |
PT1229906E (pt) * | 1999-08-31 | 2008-01-18 | Bayer Schering Pharma Ag | Mesoprogestinas para o tratamento e prevenção de distúrbios ginecológicos hormonodependentes benignos |
US8193252B1 (en) | 1999-08-31 | 2012-06-05 | Bayer Pharma AG | Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders |
US7005418B1 (en) | 1999-09-23 | 2006-02-28 | Zentaris Gmbh | Method for the therapeutic management of extrauterine proliferation of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
NZ534836A (en) * | 1999-09-23 | 2007-07-27 | Zentaris Gmbh | Method for the therapeutic management of extrauterine proliferatoin of endometrial tissue, chronic pelvic pain and fallopian tube obstruction |
AU2001269439A1 (en) * | 2000-07-05 | 2002-01-14 | Takeda Chemical Industries Ltd. | Medicinal preparations for treating sex hormone-dependent diseases |
DE10050831A1 (de) | 2000-10-05 | 2002-05-02 | Veyx Pharma Gmbh | Verfahren zum Zyklusstart bei weiblichen Zuchttieren |
IL145838A (en) * | 2000-10-16 | 2008-11-03 | Pfizer Prod Inc | Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis |
WO2002056903A2 (en) * | 2001-01-17 | 2002-07-25 | Praecis Pharmaceuticals Inc. | Methods for treating hormone associated conditions using a combination of lhrh antagonists and specific estrogen receptor modulators |
JP2003137814A (ja) * | 2001-08-10 | 2003-05-14 | Takeda Chem Ind Ltd | GnRHアゴニストの併用剤 |
EP2266567A1 (en) | 2009-05-26 | 2010-12-29 | Æterna Zentaris GmbH | Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
EP2266568A1 (en) | 2009-05-26 | 2010-12-29 | Æterna Zentaris GmbH | Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
US5457116A (en) * | 1993-10-15 | 1995-10-10 | Eli Lilly And Company | Methods of inhibiting uterine fibrosis |
US5451589A (en) * | 1993-12-21 | 1995-09-19 | Eli Lilly And Company | Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
US5451590A (en) * | 1993-12-21 | 1995-09-19 | Eli Lilly & Co. | Methods of inhibiting sexual precocity |
US5593987A (en) * | 1993-12-21 | 1997-01-14 | Eli Lilly And Company | Methods of inhibiting breast disorders |
US6096764A (en) * | 1997-08-21 | 2000-08-01 | Eli Lilly And Company | Methods for inhibiting detrimental side-effects due to GnRH of GnRH agonist administration |
-
1996
- 1996-01-29 DE DE19604231A patent/DE19604231A1/de not_active Ceased
-
1997
- 1997-01-29 BR BR9707210A patent/BR9707210A/pt not_active IP Right Cessation
- 1997-01-29 IL IL12555797A patent/IL125557A0/xx unknown
- 1997-01-29 JP JP9527295A patent/JP2000505422A/ja not_active Ceased
- 1997-01-29 HU HU9901288A patent/HUP9901288A3/hu unknown
- 1997-01-29 PL PL97328066A patent/PL328066A1/xx unknown
- 1997-01-29 ZA ZA9700741A patent/ZA97741B/xx unknown
- 1997-01-29 CN CN97191940A patent/CN1209750A/zh active Pending
- 1997-01-29 SK SK987-98A patent/SK98798A3/sk unknown
- 1997-01-29 EA EA199800666A patent/EA001178B1/ru not_active IP Right Cessation
- 1997-01-29 KR KR1019980705802A patent/KR19990082080A/ko not_active Application Discontinuation
- 1997-01-29 US US09/117,357 patent/US7309691B2/en not_active Expired - Fee Related
- 1997-01-29 TR TR1998/01452T patent/TR199801452T2/xx unknown
- 1997-01-29 WO PCT/EP1997/000395 patent/WO1997027863A1/de not_active Application Discontinuation
- 1997-01-29 EP EP97902258A patent/EP0877621A1/de not_active Withdrawn
- 1997-01-29 CZ CZ982391A patent/CZ239198A3/cs unknown
- 1997-02-14 TW TW086101753A patent/TW577735B/zh active
-
1998
- 1998-07-28 NO NO983465A patent/NO983465L/no not_active Application Discontinuation
- 1998-07-29 BG BG102660A patent/BG63248B1/bg unknown
- 1998-07-29 MX MX9806082A patent/MX9806082A/es unknown
-
2001
- 2001-08-10 US US09/925,419 patent/US20020032156A1/en not_active Abandoned
-
2002
- 2002-07-31 US US10/207,907 patent/US20020198155A1/en not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006098371A1 (ja) * | 2005-03-16 | 2006-09-21 | Masao Igarashi | 子宮内膜症および子宮腺筋症の治療剤および予防剤 |
US7705011B2 (en) | 2005-03-16 | 2010-04-27 | Masao Igarashi | Agent for treatment and prevention of endometriosos and uterine adenomyosis |
JP2013528626A (ja) * | 2010-06-16 | 2013-07-11 | アンドルシェルシュ・インコーポレイテッド | エストロゲン関連疾患を治療するまたは予防するための方法 |
JP2015147809A (ja) * | 2010-06-16 | 2015-08-20 | アンドルシェルシュ・インコーポレイテッド | エストロゲン関連疾患を治療するまたは予防するための方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1209750A (zh) | 1999-03-03 |
ZA97741B (en) | 1997-07-30 |
US20010041672A1 (en) | 2001-11-15 |
TW577735B (en) | 2004-03-01 |
BR9707210A (pt) | 1999-04-06 |
US20020032156A1 (en) | 2002-03-14 |
NO983465L (no) | 1998-09-18 |
SK98798A3 (en) | 1999-03-12 |
BG63248B1 (bg) | 2001-07-31 |
IL125557A0 (en) | 1999-03-12 |
PL328066A1 (en) | 1999-01-04 |
NO983465D0 (no) | 1998-07-28 |
TR199801452T2 (xx) | 1998-10-21 |
EA199800666A1 (ru) | 1999-02-25 |
BG102660A (en) | 1999-06-30 |
CZ239198A3 (cs) | 1998-11-11 |
KR19990082080A (ko) | 1999-11-15 |
WO1997027863A1 (de) | 1997-08-07 |
US20020198155A1 (en) | 2002-12-26 |
HUP9901288A2 (hu) | 1999-08-30 |
EP0877621A1 (de) | 1998-11-18 |
MX9806082A (es) | 1998-10-31 |
EA001178B1 (ru) | 2000-10-30 |
HUP9901288A3 (en) | 2000-03-28 |
US7309691B2 (en) | 2007-12-18 |
DE19604231A1 (de) | 1997-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2110274C1 (ru) | Способ лечения состояния, зависящего от эстрогенов яичников | |
US5340584A (en) | Methods and formulations for use in inhibiting conception and in treating benign gynecological disorders | |
US5340585A (en) | Method and formulations for use in treating benign gynecological disorders | |
JP2000505422A (ja) | 婦人科における障害を治療するためのlhrh類似化合物および抗エストロゲンからなる製薬的組み合わせ製剤 | |
JP6532754B2 (ja) | エストロゲン関連疾患を治療するまたは予防するための方法 | |
US7666836B2 (en) | Method for the therapeutic management of endometriosis | |
KR101075929B1 (ko) | 아로마타제 억제제, 프로게스틴 및 에스트로겐의 조합물을포함하는 조성물 및 자궁내막증의 치료를 위한 이의 용도 | |
KR100772852B1 (ko) | 자궁내막증 치료용 약제학적 조성물 | |
BG63363B1 (bg) | Използване на антагонист на gnrh за получаване нафармацевтичен състав за лечение на гонадостероидно зависими заболявания | |
WO1999020647A1 (fr) | Remede contre les hysteromyomes, contenant du dienogeste comme principe actif | |
AU761274B2 (en) | Pharmaceutical combination preparation that consists of LHRH-analogues and antiestrogens for treating gynecological disorders | |
CA2244675A1 (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders | |
Rock | Gonadotropin-releasing hormone agonist analogs in the treatment of uterine leiomyomas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040128 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071113 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080208 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080324 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080708 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080819 |